![Siddharthan Chandran](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Siddharthan Chandran
Founder at Pheno Therapeutics Ltd.
Network origin in Siddharthan Chandran first degree
Entity | Entity type | Industry | |
---|---|---|---|
Pheno Therapeutics Ltd.
![]() Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
SpeakUnique Ltd.
![]() SpeakUnique Ltd. Packaged SoftwareTechnology Services SpeakUnique Ltd. is a company founded in 2018 and based in Edinburgh, UK. The British company specializes in developing state-of-the-art voice banking technology that enables individuals to create high-quality, personalized synthetic voices. The company's technology allows people to communicate in their own voice when natural speech is not possible.
4
| Holding Company | Packaged Software | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Siddharthan Chandran via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
OPGEN, INC. | Miscellaneous Commercial Services | Director/Board Member | |
BG MEDICINE, INC. | Medical Specialties | Director/Board Member | |
Baillie Gifford International LLC
![]() Baillie Gifford International LLC Investment ManagersFinance Part of Baillie Gifford & Co., Baillie Gifford International LLC is an independent investment partnership founded in Edinburgh in 1908. The company is based in Edinburgh, UK. The British company focuses on long-term growth investing in some of the world's most exciting companies. With assets under management of £230bn and 1,800 staff, the company has offices in various locations. Baillie Gifford International is unique in being a large-scale investment business that has remained an independent private partnership. | Investment Managers | Director/Board Member | |
University of Glasgow | College/University | Undergraduate Degree | |
SGX Pharmaceuticals, Inc.
![]() SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Cambridge | College/University | Graduate Degree | |
SV Health Investors LLC
![]() SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Corporate Officer/Principal | |
University of London | College/University | Graduate Degree | |
Newcastle University | College/University | Doctorate Degree | |
University of Strathclyde | College/University | Undergraduate Degree | |
University of Birmingham | College/University | Doctorate Degree Doctorate Degree | |
Chroma Therapeutics Ltd.
![]() Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman | |
Novasite Pharmaceuticals, Inc.
![]() Novasite Pharmaceuticals, Inc. BiotechnologyHealth Technology Novasite Pharmaceuticals, Inc. develops optimizing genes and proteins. The private company is based in San Diego, CA and has subsidiaries in United States. The company was founded by Juan Antonio Ballesteros Nobell. | Biotechnology | Chief Executive Officer | |
SAIC-Frederick, Inc.
![]() SAIC-Frederick, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leidos Holdings, Inc., SAIC-Frederick, Inc. provides technical solutions and services. The company is based in San Diego, CA. David Heimbrook has been the CEO of the company since 2011. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Novation Pharmaceuticals, Inc.
![]() Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Medical/Nursing Services | Director/Board Member | |
Glaxo Group Research Ltd. | Corporate Officer/Principal | ||
Duran Audio BV
![]() Duran Audio BV Electronic Production EquipmentElectronic Technology Part of Samsung Electronics Co., Ltd., Duran Audio BV is a Dutch company that manufactures and distributes audio equipment. The company is based in Zaltbommel, the Netherlands. Duran Audio was acquired by Harman International Industries, Inc., part of Samsung Electronics Co., Ltd. from March 13, 2017 on October 17, 2013 for $40.47 million. | Electronic Production Equipment | Chief Tech/Sci/R&D Officer | |
Standard Property Investment Ltd.
![]() Standard Property Investment Ltd. Real Estate DevelopmentFinance Standard Property Investment Ltd. provides property development services. The company is headquartered in London, the United Kingdom. | Real Estate Development | Director/Board Member | |
Gyrasol Technologies | Director/Board Member | ||
HORIZON DISCOVERY GROUP PLC | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Cambridge Innovation Capital Ltd
![]() Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Private Equity Analyst | |
BIOVERATIV INC | Biotechnology | Corporate Officer/Principal | |
Biogen-Idec Pharmaceuticals, Inc.
![]() Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Gaithersburg, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Exvastat Ltd.
![]() Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Avvinity Therapeutics Ltd.
![]() Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | Pharmaceuticals: Major | Founder | |
Tridek-One Therapeutics SAS
![]() Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Hydrainer Pump Hire Ltd.
![]() Hydrainer Pump Hire Ltd. Finance/Rental/LeasingFinance Founded in 1980, Hydrainer Pump Hire Ltd. is a British company that leases hydraulic and electronic submersible pumps. Part of Hydrainer Holdings Ltd., the company is based in Killamarsh, UK. | Finance/Rental/Leasing | Director/Board Member | |
Orrmac (No 50) Ltd.
![]() Orrmac (No 50) Ltd. Financial ConglomeratesFinance Orrmac (No 50) Ltd. is an investment holding British company founded in 1986. The private company is based in Edinburgh, UK. | Financial Conglomerates | Director/Board Member | |
Aston Tower Multi-Academy Trust
![]() Aston Tower Multi-Academy Trust Investment Trusts/Mutual FundsMiscellaneous Aston Tower Multi-Academy Trust is a British educational institution management company founded in 2016. The non-profit company is based in Birmingham, UK. The company manages educational institutions. | Investment Trusts/Mutual Funds | Director/Board Member | |
Alliance Manchester Business School | College/University | Masters Business Admin | |
The School of Pharmacy University of London | College/University | Doctorate Degree | |
Pencil Biosciences Ltd.
![]() Pencil Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pencil Biosciences Ltd. develops gene modulation technology. The company was founded on November 5, 2018 and is headquartered in Macclesfield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Montis Biosciences BV
![]() Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | Biotechnology | Director/Board Member | |
Alsa Management Services Ltd
![]() Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Baillie Gifford International LLC (United States)
![]() Baillie Gifford International LLC (United States) Investment ManagersFinance Baillie Gifford International LLC (BGI) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2005 and is a wholly owned subsidiary of Baillie Gifford Overseas Ltd. (BGO), which is owned by Baillie Gifford & Co. in Great Britain. BGI serves as the investment manager for pooled investment vehicles, which includes the Group Trust and Private Companies Fund. | Investment Managers | Chief Executive Officer | |
Pandeia Therapeutics Ltd. | Founder | ||
Turbine Simulated Cell Technologies Ltd.
![]() Turbine Simulated Cell Technologies Ltd. Information Technology ServicesTechnology Services Turbine Simulated Cell Technologies Ltd. is a British company that leverages AI technology to understand oncology patients with simulated cells. The company is based in London, UK. and has subsidiaries in Hungary. The company was founded in 2019 by Szabolcs Nagy, Ivan Fekete, Daniel Veres, Kristof Zsolt Szalay. Szabolcs Nagy has been the CEO since 2019. | Information Technology Services | Director/Board Member | |
Maxion Therapeutics Ltd.
![]() Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
PERELLA WEINBERG PARTNERS | Investment Banks/Brokers | Corporate Officer/Principal | |
Epitopea Ltd.
![]() Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021. | Miscellaneous Commercial Services | Founder | |
Lifearc Ventures
![]() Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Horizon Discovery Ltd.
![]() Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer |
Statistics
International
United Kingdom | 29 |
United States | 18 |
Canada | 2 |
Netherlands | 2 |
France | 2 |
Sectoral
Health Technology | 17 |
Finance | 12 |
Consumer Services | 9 |
Commercial Services | 8 |
Health Services | 2 |
Operational
Director/Board Member | 73 |
Corporate Officer/Principal | 12 |
Independent Dir/Board Member | 9 |
Chief Executive Officer | 9 |
Founder | 8 |
Most connected contacts
Insiders | |
---|---|
Raj Bhikhu Parekh | 50 |
Timothy Harris | 19 |
Sohaib Mir | 10 |
Jonathan Moore | 9 |
Fraser Murray | 8 |
Neil Carragher | 7 |
Angus Macdonald | 4 |
Timothy Campbell | 3 |
Jane Rhodes | 3 |
Kevin Doyle | 1 |
Euan Macdonald | 1 |
- Stock Market
- Insiders
- Siddharthan Chandran
- Company connections